n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide and Graft-vs-Host-Disease

n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide has been researched along with Graft-vs-Host-Disease* in 1 studies

Other Studies

1 other study(ies) available for n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide and Graft-vs-Host-Disease

ArticleYear
Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function.
    Leukemia, 2016, Volume: 30, Issue:4

    Topics: Animals; Benzamides; Cells, Cultured; Disease Models, Animal; Graft vs Host Disease; Humans; Janus Kinases; Mice; Mice, Inbred BALB C; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrimidines; T-Lymphocytes

2016